Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily E Karn

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Investigative Dermatology|November 16, 2025
Comparative analysis of staging and metastatic risk stratification systems for cutaneous squamous cell carcinomaMonika Bapna, Emily E Karn, William Lotter, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 4, 2025
Changes in Patient Perceptions of the Cost of Mohs Micrographic Surgery: A Multiyear Cross-Sectional Survey StudyMichael S Chang, Emily E Karn, Chrysalyne D Schmults, et al.
Proceedings of Machine Learning Research|May 25, 2026
Leveraging Foundation Models for Histological Grading in Cutaneous Squamous Cell Carcinoma using PathFMToolsAbdul Rahman Diab, Emily E Karn, Renchin Wu, et al.
Journal of the American Academy of Dermatology|March 12, 2026
Optimizing Acitretin Monitoring and Discontinuation: A Multicenter Retrospective Study on Laboratory Abnormalities, Adverse Effects, and Post-Treatment Cutaneous Squamous Cell Carcinoma RiskBina Kassamali, Madeline McNamara, Emily E Karn, et al.
Journal of the American Academy of Dermatology|September 26, 2025
Efficacy of 0.25% timolol gel in healing surgical open wounds: A randomized clinical trialNancy Anabaraonye, Nina Ran, Emily E Karn, et al.
Journal of the American Academy of Dermatology|September 21, 2023
Definitive radiation therapy for inoperable stage III/IV cutaneous squamous cell carcinoma: A single-institution retrospective cohort studyEmily E Granger, Emily Y Kim, Emily E Karn, et al.
Future Oncology (London, England)|September 4, 2024
Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profileEmily S Ruiz, Karina Brito, Emily E Karn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 22, 2026
Mohs surgery reduces recurrence for dermatofibrosarcoma protuberans: A multicentre cohort studyBina Kassamali, Catherine E Pisano, Nina A Ran, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-055: Metastasis-Free Survival Prediction With the 40-Gene Expression Profile Test in Patients With Cutaneous Squamous Cell Carcinoma Risk Stratified According to the National Comprehensive Cancer Network GuidelinesEmily S Ruiz, Karina Brito, Emily E Karn, et al.
Journal of the American Academy of Dermatology|October 11, 2025
Patterns of disease-specific death from cutaneous squamous cell carcinoma: A multicenter retrospective cohortFrederick T Gibson, Nina A Ran, Emily E Karn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology|November 16, 2025
Comparative analysis of staging and metastatic risk stratification systems for cutaneous squamous cell carcinomaMonika Bapna, Emily E Karn, William Lotter, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 4, 2025
Changes in Patient Perceptions of the Cost of Mohs Micrographic Surgery: A Multiyear Cross-Sectional Survey StudyMichael S Chang, Emily E Karn, Chrysalyne D Schmults, et al.
Proceedings of Machine Learning Research|May 25, 2026
Leveraging Foundation Models for Histological Grading in Cutaneous Squamous Cell Carcinoma using PathFMToolsAbdul Rahman Diab, Emily E Karn, Renchin Wu, et al.
Journal of the American Academy of Dermatology|March 12, 2026
Optimizing Acitretin Monitoring and Discontinuation: A Multicenter Retrospective Study on Laboratory Abnormalities, Adverse Effects, and Post-Treatment Cutaneous Squamous Cell Carcinoma RiskBina Kassamali, Madeline McNamara, Emily E Karn, et al.
Journal of the American Academy of Dermatology|September 26, 2025
Efficacy of 0.25% timolol gel in healing surgical open wounds: A randomized clinical trialNancy Anabaraonye, Nina Ran, Emily E Karn, et al.
Journal of the American Academy of Dermatology|September 21, 2023
Definitive radiation therapy for inoperable stage III/IV cutaneous squamous cell carcinoma: A single-institution retrospective cohort studyEmily E Granger, Emily Y Kim, Emily E Karn, et al.
Future Oncology (London, England)|September 4, 2024
Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profileEmily S Ruiz, Karina Brito, Emily E Karn, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 22, 2026
Mohs surgery reduces recurrence for dermatofibrosarcoma protuberans: A multicentre cohort studyBina Kassamali, Catherine E Pisano, Nina A Ran, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-055: Metastasis-Free Survival Prediction With the 40-Gene Expression Profile Test in Patients With Cutaneous Squamous Cell Carcinoma Risk Stratified According to the National Comprehensive Cancer Network GuidelinesEmily S Ruiz, Karina Brito, Emily E Karn, et al.
Journal of the American Academy of Dermatology|October 11, 2025
Patterns of disease-specific death from cutaneous squamous cell carcinoma: A multicenter retrospective cohortFrederick T Gibson, Nina A Ran, Emily E Karn, et al.
Pageof 2